J. Nabel Gary's Insider Trades & SAST Disclosures
J. Nabel Gary's most recent trade in Opko Health Inc was a trade of 437,500 Common Stock done . Disclosure was reported to the exchange on July 24, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern J. Nabel Gary.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Opko Health Inc | Gary J. Nabel | Director, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2024 | 437,500 | 700,579 (0%) | 0% | 0 | Common Stock | |
| Candel Therapeutics Inc | Gary J. Nabel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| SIGA Technologies Inc | Gary J. Nabel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2024 | 24,712 | 50,928 (0%) | 0% | - | Common Stock, par value $.0001 per share | |
| SIGA Technologies Inc | Gary J. Nabel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2024 | 24,712 | 0 | - | - | Restricted Stock Units | |
| SIGA Technologies Inc | Gary J. Nabel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 19,084 | 19,084 | - | - | Restricted Stock Units | |
| SIGA Technologies Inc | Gary J. Nabel | Director | Sale or transfer of securities back to the company at price $ 7.86 per share. | 11 Jun 2024 | 7,414 | 43,514 (0%) | 0% | 7.9 | 58,274 | Common Stock, par value $.0001 per share |
| Opko Health Inc | Nabel Gary J. | Director, Chief Innovation Officer | Purchase of securities on an exchange or from another person at price $ 0.93 per share. | 08 Jan 2024 | 108,695 | 351,442 (0%) | 0% | 0.9 | 100,543 | Common Stock |
| Opko Health Inc | Nabel Gary J. | Director, Chief Innovation Officer | Purchase of securities on an exchange or from another person at price $ 0.93 per share. | 08 Jan 2024 | 106,989 | 107,489 (0%) | 0% | 0.9 | 99,425 | Common Stock |
| Opko Health Inc | J. Nabel Gary | Director, Chief Innovation Officer | Purchase of securities on an exchange or from another person at price $ 0.92 per share. | 08 Jan 2024 | 500 | 500 (0%) | 0% | 0.9 | 459 | Common Stock |
| Candel Therapeutics Inc | Gary J. Nabel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 14,240 | 14,240 | - | - | Stock Option (Right to Buy) | |
| SIGA Technologies Inc | Gary J. Nabel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 24,712 | 24,712 | - | - | Restricted Stock Units | |
| SIGA Technologies Inc | Gary J. Nabel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2023 | 14,620 | 30,602 (0%) | 0% | - | Common Stock, par value $.0001 per share | |
| SIGA Technologies Inc | Gary J. Nabel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2023 | 14,620 | 0 | - | - | Restricted Stock Units | |
| SIGA Technologies Inc | Gary J. Nabel | Director | Sale or transfer of securities back to the company at price $ 6.07 per share. | 13 Jun 2023 | 4,386 | 26,216 (0%) | 0% | 6.1 | 26,623 | Common Stock, par value $.0001 per share |
| Opko Health Inc | Gary J. Nabel | Director, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 700,000 | 700,000 | - | - | Stock Option (Right to Buy) | |
| Opko Health Inc | Gary J. Nabel | Director, Chief Innovation Officer | Purchase of securities on an exchange or from another person at price $ 1.82 per share. | 05 May 2023 | 79,334 | 232,676 (0%) | 0% | 1.8 | 144,388 | Common Stock |
| Opko Health Inc | Gary J. Nabel | Director, Chief Innovation Officer | Purchase of securities on an exchange or from another person at price $ 1.82 per share. | 05 May 2023 | 54,945 | 19,912,459 (2%) | 0% | 1.8 | 100,000 | Common Stock |
| Opko Health Inc | Gary J. Nabel | Director, Chief Innovation Officer | Purchase of securities on an exchange or from another person at price $ 1.84 per share. | 05 May 2023 | 54,346 | 168,684 (0%) | 0% | 1.8 | 99,991 | Common Stock |
| Opko Health Inc | Gary J. Nabel | Director, Chief Innovation Officer | Purchase of securities on an exchange or from another person at price $ 1.85 per share. | 05 May 2023 | 54,054 | 242,747 (0%) | 0% | 1.9 | 100,000 | Common Stock |
| Opko Health Inc | Gary J. Nabel | Director, Chief Innovation Officer | Purchase of securities on an exchange or from another person at price $ 1.84 per share. | 05 May 2023 | 34,338 | 114,338 (0%) | 0% | 1.8 | 63,113 | Common Stock |
| Opko Health Inc | Gary J. Nabel | Director, Chief Innovation Officer | Purchase of securities on an exchange or from another person at price $ 1.82 per share. | 05 May 2023 | 28,538 | 19,886,052 (2%) | 0% | 1.8 | 51,939 | Common Stock |
| Opko Health Inc | Gary J. Nabel | Director, Chief Innovation Officer | Purchase of securities on an exchange or from another person at price $ 1.80 per share. | 05 May 2023 | 27,777 | 125,718 (0%) | 0% | 1.8 | 49,999 | Common Stock |
| Opko Health Inc | Gary J. Nabel | Director, Chief Innovation Officer | Purchase of securities on an exchange or from another person at price $ 1.81 per share. | 05 May 2023 | 27,624 | 153,342 (0%) | 0% | 1.8 | 49,999 | Common Stock |
| Opko Health Inc | Gary J. Nabel | Director, Chief Innovation Officer | Purchase of securities on an exchange or from another person at price $ 1.85 per share. | 05 May 2023 | 26,407 | 19,912,459 (2%) | 0% | 1.9 | 48,853 | Common Stock |
| Opko Health Inc | Gary J. Nabel | Director, Chief Innovation Officer | Purchase of securities on an exchange or from another person at price $ 1.85 per share. | 05 May 2023 | 20,009 | 188,693 (0%) | 0% | 1.8 | 36,961 | Common Stock |
| Opko Health Inc | Gary J. Nabel | Director, Chief Innovation Officer | Purchase of securities on an exchange or from another person at price $ 1.83 per share. | 05 May 2023 | 19,475 | 252,151 (0%) | 0% | 1.8 | 35,620 | Common Stock |
| Opko Health Inc | Gary J. Nabel | Director, Chief Innovation Officer | Purchase of securities on an exchange or from another person at price $ 1.78 per share. | 05 May 2023 | 19,285 | 94,756 (0%) | 0% | 1.8 | 34,327 | Common Stock |
| Opko Health Inc | Gary J. Nabel | Director, Chief Innovation Officer | Purchase of securities on an exchange or from another person at price $ 1.83 per share. | 05 May 2023 | 10,928 | 263,079 (0%) | 0% | 1.8 | 19,998 | Common Stock |
| Opko Health Inc | Gary J. Nabel | Director, Chief Innovation Officer | Purchase of securities on an exchange or from another person at price $ 1.79 per share. | 05 May 2023 | 3,185 | 97,941 (0%) | 0% | 1.8 | 5,711 | Common Stock |
| Candel Therapeutics Inc | Gary J. Nabel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2022 | 28,480 | 28,480 | - | - | Stock Option (Right to Buy) | |
| SIGA Technologies Inc | Gary J. Nabel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2022 | 22,831 | 22,831 (0%) | 0% | - | Common Stock, par value $.0001 per share | |
| SIGA Technologies Inc | Gary J. Nabel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2022 | 22,831 | 0 | - | - | Restricted Stock Units | |
| SIGA Technologies Inc | Gary J. Nabel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 14,620 | 14,620 | - | - | Restricted Stock Units | |
| SIGA Technologies Inc | Gary J. Nabel | Director | Sale or transfer of securities back to the company at price $ 10.26 per share. | 14 Jun 2022 | 6,849 | 15,982 (0%) | 0% | 10.3 | 70,271 | Common Stock, par value $.0001 per share |
| Opko Health Inc | Gary J. Nabel | Director, Chief Innovation Officer | Purchase of securities on an exchange or from another person at price $ 2.90 per share. | 12 May 2022 | 68,492 | 75,471 (0%) | 0% | 2.9 | 198,627 | Common Stock |
| Opko Health Inc | Gary J. Nabel | Director, Chief Innovation Officer | Purchase of securities on an exchange or from another person at price $ 2.65 per share. | 12 May 2022 | 6,979 | 6,979 (0%) | 0% | 2.6 | 18,494 | Common Stock |
| Opko Health Inc | Gary J. Nabel | Director, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2022 | 19,777,514 | 19,777,514 (2%) | 2% | - | Common Stock | |
| Opko Health Inc | Gary J. Nabel | Director, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2022 | 19,777,514 | 19,777,514 (2%) | 2% | - | Common Stock | |
| SIGA Technologies Inc | Gary J. Nabel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 25,000 | 25,000 | - | - | Stock Option (Right to buy) | |
| SIGA Technologies Inc | Gary J. Nabel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 22,831 | 22,831 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges